Core Insights - Scienture Holdings, Inc. is participating in the 8th Annual Conference of The Society for the Study of Xenobiotics (SSX) India, focusing on drug discovery and development [1][3] - Dr. Narasimhan Mani will present on technology-driven product innovations and market strategies in the specialty pharmaceutical industry [2][5] - The SSX conference aims to facilitate knowledge sharing among scientists and industry experts in the field of drug discovery [3] Company Overview - Scienture Holdings, Inc. operates through its subsidiaries, focusing on providing novel specialty pharmaceutical products to meet unmet market needs [5] - The company is involved in various therapeutic areas and markets, including government organizations, hospitals, and independent pharmacies [5] Conference Details - The SSX 2025 Conference will take place from January 23-25, 2025, at BITS Pilani, Hyderabad Campus [1] - The event will feature expert panels, presentations, and networking opportunities with industry veterans [7]
Scienture Holdings, Inc. Announces Dr. Narasimhan Mani's Participation in the 8th Annual Conference of The Society for the Study of Xenobiotics